Skip to main content

Table 2 Prevalence of hepatitis markers among the participants grouped according to their age

From: Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008–2009

Age group HBsAg anti-HBs anti-HBc
No. positive/no.tested % 95%CI No. positive/no.tested % 95%CI No. positive/no.tested % 95%CI
Children
6 mos – <5 yrs 0/432 0.0% 0.0-1.1 424/432 98.1% 96.2-99.1 0/432 0.0% 0.0-1.1
Adolescent
16-20 yrs 7/124 5.6% 2.3-11.3 22/124 17.7% 11.5-25.6 11/124 8.9% 4.5-15.3
Adult (n = 370)
21-29 yrs 2/124 1.6% 0.2-5.7 34/124 27.4% 19.8-36.2 22/124 17.7% 11.5-25.6
30-39 yrs 5/123 4.1% 1.3-9.2 39/123 31.7% 23.6-40.7 27/123 22.0% 15.0-30.3
40-49 yrs 5/123 4.1% 1.3-9.2 34/123 27.6% 20.0-36.4 26/123 21.1% 14.3-29.4
Total 19/926 2.0% 1.3-3.2 553/926 59.7% 56.5-62.9 86/926 9.2% 7.5-11.3